PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
$8,50
0,00%
(0,00) 1G
12 Eki, 10:22:09 GMT-4 · USD
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoPTKFY ile ilgili en önemli analizler oluşturuluyor...
Piy. değ.
31,60 Tn
Ort. hacim
1,96 B
İşlem Hacmi
148,00
52 haftalık en yüksek
$16,36
52 haftalık en düşük
$7,63
Beta
0,09
Tedavüldeki hisse senedi sayısı
234,07 Mn
Çalışan sayısı
13 B
Piy. değ.
31,60 Tn
Ort. hacim
1,96 B
İşlem Hacmi
148,00
52 haftalık en yüksek
$16,36
52 haftalık en düşük
$7,63
Beta
0,09
Tedavüldeki hisse senedi sayısı
234,07 Mn
Çalışan sayısı
13 B
Haberler
Web kaynaklarından ve haber iş ortaklarından
ad-hoc-news.de
·
1 saat önce
Indo Premier sees Kalbe Farma stock earnings beating estimates
ad-hoc-news.de
·
1 gün önce
Kalbe Farma launches IDR 500 billion buyback while Kiwoom targets Kalbe Farma stock
ad-hoc-news.de
·
1 gün önce
Kalbe Farma launched an IDR 500 billion buyback of Kalbe Farma stock
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
PT Kalbe Farma Unsponsored Indonesia ADR hakkında